HELODIP 3.1 % W/V TEAT DIP CONCENTRATE
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
07-06-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
AMMONIUM LAURYL SULFATE
Available from:
Bimeda Holdings PLC
ATC code:
QD08AX
Dosage:
3.1 %w/v
Pharmaceutical form:
Teat Dip
Therapeutic group:
Antiseptics
Therapeutic area:
Bovine
Authorization date:
1994-06-20
Summary of Product characteristics
IRISH MEDICINES BOARD ACT 1995
EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007
(S.I. NO. 786 OF 2007)
VPA: 10959/009/001
Case No: 7007267
The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby
grants to:
BIMEDA HOLDINGS PLC
BROOMHILL ROAD, TALLAGHT, DUBLIN 24, IRELAND
an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the
Veterinary Medicinal Product:
HELODIP 3.1 % W/V TEAT DIP CONCENTRATE
The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may
be specified in the said Schedule.
The authorisation,unless revoked, shall continue in force from 15/02/2010.
Signed on behalf of the Irish Medicines Board
________________
A person authorised in that behalf by the said Board.
(NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.)
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 16/02/2010_
_CRN 7007267_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Helodip 3.1 % w/v Teat Dip Concentrate
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Teat dip concentrate.
A clear, faintly opalescent, yellow slightly viscous solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
To reduce the incidence of mastitis in lactating cows and heifers. Also, to maintain the skin condition of the udder.
4.3 CONTRA
Read the complete document
